We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Genetic Defects Traced in DiGeorge Syndrome

By Biotechdaily staff writers
Posted on 21 Feb 2003
Researchers have discovered that vascular endothelial growth factor (VEGF) is a modifier of DiGeorge syndrome, which is characterized by the hemizygous deletion of chromosome 22q11 (del22q11). More...
Their findings were reported in the February 2003 issue of Nature Medicine.

DiGeorge syndrome can cause a wide range of heart defects, many of which are vascular in nature, as well as problems with the thymus and parathyroid gland, craniofacial abnormalities, and mental retardation.

The genome of 60-70% of victims of DiGeorge syndrome lacks chromosome 22, which represents a loss of a group of 24 genes. One of these genes, Tbx1, had been considered to be the primary gene involved in DiGeorge syndrome. Researchers from the Medical College of Georgia (Augusta, USA; www.mcg.edu) and Catholic University Leuven (Belgium; www.leuven.ac.be) realized that the wide variety of syndromes presented by sufferers implied the role of other genes, such as that for VEGF.

"It struck us that in the mouse model for DiGeorge syndrome, a lot of the heart defects are vascular in nature, so we looked at one of the major vascular genes, VEGF,” explained senior American investigator Dr. Simon J. Conway, a developmental biologist at the Medical College of Georgia. "If you knock out VEGF from a mouse model, it dies very, very early, before you get a heart, a head, even before you see an embryo proper.”

Working with a VEGF knockout mouse developed by the Belgian group, the investigators found that only the 164/164 form of the VEGF gene was critical to the development of DiGeorge syndrome. Mice lacking this gene developed symptoms similar to DiGeorge syndrome. Dr. Conway explained that something on chromosome 22 was working with VEGF, and that it probably was Tbx1, and that a reduction in Tbx1 and a corresponding reduction in VEGF were enough to produce DiGeorge syndrome.





Related Links:
Medical College of Georgia
Catholic University Leuven

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.